Dean Richard Artis
CIK: 0001958523
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Annexon, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 2, 2026ANNX
Annexon, Inc.
Sale(S)Direct5.9K shares at avg. $5.43$32K - Feb 19, 2026ANNX
Annexon, Inc.
Award(A)Direct62.5K shares- - Feb 18, 2026ANNX
Annexon, Inc.
Sale(S)Direct5.3K shares at avg. $5.10$27K - Feb 27, 2025ANNX
Annexon, Inc.
Award(A)DirectStock Option (Right to Buy)
272.6K shares- - Feb 18, 2025ANNX
Annexon, Inc.
Sale(S)Direct5.5K shares at avg. $2.97$16K - Feb 27, 2024ANNX
Annexon, Inc.
Award(A)Direct45K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | ANNX Annexon, Inc. | Sale(S) | 5,894 | $5.43 | $32,004 | Direct |
| Feb 19, 2026 | ANNX Annexon, Inc. | Award(A) | 62,500 | - | $0 | Direct |
| Feb 18, 2026 | ANNX Annexon, Inc. | Sale(S) | 5,290 | $5.10 | $26,979 | Direct |
| Feb 27, 2025 | ANNX Annexon, Inc. | Award(A) Stock Option (Right to Buy) | 272,575 | - | - | Direct |
| Feb 18, 2025 | ANNX Annexon, Inc. | Sale(S) | 5,515 | $2.97 | $16,380 | Direct |
| Feb 27, 2024 | ANNX Annexon, Inc. | Award(A) | 44,963 | - | - | Direct |
1-6 of 6 transactions
About ARTIS DEAN RICHARD
ARTIS DEAN RICHARD (SEC CIK 0001958523) files insider reports with the SEC as EVP & CHIEF SCIENTIFIC OFFICER of Annexon, Inc. (ANNX).
Signal8 holds 5 ownership filings by ARTIS DEAN RICHARD, all Form 4s, filed between Feb 20, 2025 and Mar 4, 2026. Those filings report 6 transactions, from Feb 27, 2024 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ARTIS DEAN RICHARD's filings is in BRISBANE, CA.
Recent filings by ARTIS DEAN RICHARD
- Mar 2, 2026: Open-market sale of ANNX shares (Form 4, code S).
- Feb 19, 2026: Grant or award of ANNX shares (Form 4, code A).
- Feb 18, 2026: Open-market sale of ANNX shares (Form 4, code S).
- Feb 27, 2025: Grant or award of ANNX derivative securities (Form 4, code A).
- Feb 18, 2025: Open-market sale of ANNX shares (Form 4, code S).
Other insiders filing for Annexon, Inc. (ANNX)
- Love Douglas, PRESIDENT AND CEO
- Blumenkranz Mark S., Director
- Waddill William D., Director
- Satter Muneer A, Director
- JONES WILLIAM A JR, Director
- Cockroft Bettina M., Director